Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

300 та иш

Иш: Lipid nanoparticle–based mRNA platforms for mucosal HIV vaccines: formulation advances, immune mechanisms, and translational pathways

  1. The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy

    Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou +5

    Шарҳ мақола20257 иқтибос
    ABI

  2. Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy

    He Lian, Huijun Yang, Jianli Tang +11

    Мақола20194 иқтибос
    ABI

  3. An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination

    Hanqi Zhang, Buzi Cao, Qingtai Cao +3

    Шарҳ мақола20234 иқтибос
    ABI

  4. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2

    Sam Afkhami, Michael R. D’Agostino, Ali Zhang +26

    Мақола20223 иқтибос
    ABI

  5. Lipid nanoparticles for mRNA delivery

    Xucheng Hou, Tal Zaks, Róbert Langer +1

    Шарҳ мақола20213 иқтибос
    ABI

  6. Human IgG and IgA responses to COVID-19 mRNA vaccines

    Adam V. Wisnewski, Julian Campillo Luna, Carrie A. Redlich

    Мақола20213 иқтибос
    ABI

  7. Macrophage-targeted nanomedicine for chronic diseases immunotherapy

    Yuejia Song, Yaqian Huang, Fang Zhou +2

    Мақола20213 иқтибос
    ABI

  8. Innate immune mechanisms of mRNA vaccines

    Rein Verbeke, Michael J. Hogan, Karin Loré +1

    Шарҳ мақола20223 иқтибос
    ABI

  9. Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies

    Yilai Jia, Boyang Fu, Liping Dong +1

    Шарҳ мақола20233 иқтибос
    ABI

  10. Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

    Jialiang Wang, Yaopeng Ding, K. Chul Chong +7

    Шарҳ мақола20243 иқтибос
    ABI

  11. Preparation of artificial substrate binding sites of nanozyme with “modular structure” strategy used for the construction of visual sensing analysis platform for levodopa

    Tianhao Li, Liuyue Xiao, Hui Ling +2

    Мақола20253 иқтибос
    ABI

  12. Effect of molecular weight of chitosan on the physicochemical, morphological, and biological properties of polyplex nanoparticles intended for gene delivery

    María E. Aranda-Barradas, Saul E. Trejo-López, Alicia Del Real +5

    Мақола20222 иқтибос
    ABI

  13. Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems

    Twana Mohammed M. Ways, Wing Man Lau, Vitaliy V. Khutoryanskiy

    Шарҳ мақола20182 иқтибос
    ABI

  14. The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

    Sonia Ndeupen, Zhen Qin, Sonya Jacobsen +3

    Мақола20212 иқтибос
    ABI

  15. Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient In Vivo Immune Responses

    Mahboubeh Ebrahimian, Maryam Hashemi, Mohsen Maleki +4

    Мақола20172 иқтибос
    ABI

  16. The effect of surface charge on oral absorption of polymeric nanoparticles

    Xiao‐Jiao Du, Jilong Wang, Shoaib Iqbal +5

    Мақола20182 иқтибос
    ABI

  17. PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production

    Takuya Suzuki, Yuta Suzuki, Taro Hihara +6

    Мақола20202 иқтибос
    ABI

  18. Mucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin

    Hongbo Cheng, Zhixiang Cui, Shuang Guo +3

    Мақола20212 иқтибос
    ABI

  19. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection

    Salma Sheikh‐Mohamed, Baweleta Isho, Gary Chao +37

    Мақола20222 иқтибос
    ABI

  20. Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery

    Yuhong Lin, Beini Sun, Zheng Jin +1

    Мақола20222 иқтибос
    ABI

  21. Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells

    Marco Künzli, Stephen D. O’Flanagan, Madeleine LaRue +16

    Мақола20222 иқтибос
    ABI

  22. Copper carbonate nanoparticles as an effective biomineralized carrier to load macromolecular drugs for multimodal therapy

    Liping Dong, Jinsong Ding, Lemei Zhu +3

    Мақола20232 иқтибос
    ABI

  23. Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease

    Ke Xu, Bingqian Gao, Jiayi Li +3

    Мақола20232 иқтибос
    ABI

  24. Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics

    Yeji Lee, Michaela Jeong, Jeongeun Park +2

    Шарҳ мақола20232 иқтибос
    ABI

  25. Lipid nanoparticles for local delivery of mRNA to the respiratory tract: Effect of PEG-lipid content and administration route

    Melike Ongun, Abhijeet Lokras, Saahil Baghel +7

    Мақола20242 иқтибос
    ABI